Salta al contenuto principale
Passa alla visualizzazione normale.

Ricerca avanzata per:

Risultati della ricerca

  • 1. didatweb.scheda.trasparenza (14) (100%)

    8-ott-2023 20.35.09

    -literary trial of level secondary post and is to a level that, characterized by the use of books ... the historical-literary trial of level secondary post and is to a level that, characterized by the use ... ability of epistemological bases of the literary research and the historical-literary trial of post ... of epistemological bases of the literary research and the historical-literary trial of post secondary

  • 2. Matematica CTF 5.3.14 Risultati e calendario colloqui (77%)

    6-mar-2014 16.57.54

    Microsoft® Word 2010 Trial Microsoft® Word 2010 Trial

  • 3. PROGRAMMA MATEMATICA e FISICA CTF 13/14 (72%)

    24-ott-2013 12.23.24

    93/94 programma, ctf, corso Antonio B Microsoft® Word 2010 Trial Microsoft® Word 2010 Trial

  • 4. Legenda dataset (67%)

    9-lug-2015 10.50.35

    LEGENDA DATASET Tab. 1 Description of trials included in the meta-analysis Meta- Author Publisher Treatment* # of # of trials # of trial analysis Ctr exp trials eliminated included 1 Myers RP et al, The Cochrane Untreated or IFN1 54 31 23 2002 Collaboration placebo 2 Brok J et al, The Cochrane IFN1 IFN2 72 54 18 2006 Collaboration 3 Hauser G et al, The Cochrane IFN1 or IFN2 IFN3 27 12 15 2014 Collaboration 4 Chou R et al, Ann Int Med IFN3 IFN4 5 0 5 2013 Total 158 97 61

  • 5. Dataset Meta-Analysis HCV (64%)

    9-lug-2015 10.50.28

    Foglio1 Meta-analysis Group Author Journal Year of publication Trial* Arm Type Patient Type Treatment SVR ITT 1 Camps J Hepatol 1993 1 exp naive interferon (IFN1) 13 36 1 Capra J Hepatol 1993 2 exp naive interferon (IFN1) 12 20 1 Causse Gastroenterology 1991 3 exp naive interferon (IFN1) 4 30 1 Causse Gastroenterology 1991 3 exp naive interferon (IFN1) 1 30 1 Cimino Ital J Gastroenter 1991 4 exp naive interferon (IFN1) 10 33 1 Davis N Eng J Med 1989 5 exp naive interferon (IFN1) 22 58 1

  • 6. Progetto PRIN ATTANASIO (60%)

    17-set-2019 20.22.36